New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
06:35 EDTWX, ILMNWuXi PharmaTech purchases Illumina HiSeq X Ten Sequencing System
Illumina (LMN) and WuXi PharmaTech (WX) announced that the WuXi Genome Center has purchased an Illumina HiSeq X Ten sequencing system. This new investment will enable WuXi’s clinical genomic services to expand from the current target panel, exome, and transcriptome scale sequencing to population genome scale sequencing. It puts the world’s most advanced gene sequencing capability in the hands of the leading pharmaceutical R&D services company in the Asia Pacific region. The WuXi Genome Center meets international clinical standards and is the only CLIA-certified clinical genomics lab in China. In addition to offering sequencing services, WuXi’s genomics lab also provides assay development, validation, and testing services.
News For WX;ILMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
19:20 EDTWXWuXi consortium to acquire Ambrx
A consortium consisting of entities affiliated with Fosun Pharmaceutical, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech (WX) announced that it has signed a merger agreement to acquire Ambrx (AMBX). The transaction is expected to close in Q2. Chairman Chen Qiyu of Fosun Pharma said, "This joint acquisition will result in great synergy with [our] current R&D system and platform. Under the help of Fosun Pharma, Ambrx's business expanding in China will enable Chinese patients to get faster access to innovative therapeutic drugs." Ge Li, CEO of Wuxi, remarked, "This transaction will allow WuXi to broadly access Ambrx's best-in-class ADC platform and biologics development capabilities."
May 19, 2015
09:18 EDTILMNBofA/Merrill life sciences analysts hold an analyst/industry conference call
Analysts, along with Nancy J. Kelley, a nationally recognized executive and lawyer who has championed the field of Synthetic/Engineering Biology in the U.S., discuss what Synthetic Biology is and whether it will disrupt the Healthcare landscape and how Synthetic Biologic-based products would be regulated on an Analyst/Industry conference call to be held on May 19 at 2 pm.
May 18, 2015
16:07 EDTILMNIllumina files new patent infringement suit against Roche unit
Subscribe for More Information
May 13, 2015
16:35 EDTWXWuXi PharmaTech backs FY15 non-GAAP EPS view $1.73-$1.78, consensus $1.76
Subscribe for More Information
16:33 EDTWXWuXi PharmaTech reports Q1 EPS 36c, consensus 32c
Reports Q1 revenue $180.0M, consensus $174.15M.
15:04 EDTWXNotable companies reporting after market close
Subscribe for More Information
08:06 EDTWXWuXi PharmaTech formes special committee to evaluate non-binding proposal
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use